FXR1 and cancer: Amplification of FXR1 mRNA expression was prevalent in all of the 32 cancers examined, with the exceptions being LAML, ACC, CHOL, COAD, DLBC, KICH, MESO, PCPG, THCA, and UVM (as illustrated in Fig. 10C).